129 related articles for article (PubMed ID: 37244817)
1. Reply to Zhipeng Mai, Weigang Yan, and Zhien Zhou's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2023 Aug; 84(2):e48-e49. PubMed ID: 37244817
[No Abstract] [Full Text] [Related]
2. Reply to André Pontes-Silva's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2024 Feb; 85(2):e45-e46. PubMed ID: 37743197
[No Abstract] [Full Text] [Related]
3. Reply to Matthias May, Ingmar Wolff, and Sabine D. Brookman-May's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Ilie G; Rutledge RDH
Eur Urol; 2024 Feb; 85(2):e49-e50. PubMed ID: 37743193
[No Abstract] [Full Text] [Related]
4. Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolás Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Ilie G; David Harold Rutledge R
Eur Urol; 2023 Jul; 84(1):e26-e27. PubMed ID: 37127468
[No Abstract] [Full Text] [Related]
5. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. 2023;83:561-70.
Mai Z; Yan W; Zhou Z
Eur Urol; 2023 Aug; 84(2):e46-e47. PubMed ID: 37244814
[No Abstract] [Full Text] [Related]
6. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
Pontes-Silva A
Eur Urol; 2024 Feb; 85(2):e43-e44. PubMed ID: 37758572
[No Abstract] [Full Text] [Related]
7. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.
May M; Wolff I; Brookman-May SD
Eur Urol; 2024 Feb; 85(2):e47-e48. PubMed ID: 37743196
[No Abstract] [Full Text] [Related]
8. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Plata M; Cesar DR; Badillo N
Eur Urol; 2023 Jul; 84(1):e24-e25. PubMed ID: 37147212
[No Abstract] [Full Text] [Related]
9. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial.
Ilie G; Rendon R; Mason R; MacDonald C; Kucharczyk MJ; Patil N; Bowes D; Bailly G; Bell D; Lawen J; Ha M; Wilke D; Massaro P; Zahavich J; Kephart G; Rutledge RDH
Eur Urol; 2023 Jun; 83(6):561-570. PubMed ID: 36822969
[TBL] [Abstract][Full Text] [Related]
10. Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
Tosoian JJ; Trock BJ; Ballentine Carter H; Mamawala M
Eur Urol; 2017 Jan; 71(1):e13. PubMed ID: 27311363
[No Abstract] [Full Text] [Related]
11. Re: A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial.
Majumdar JR; Carlsson SV
Eur Urol; 2023 Sep; 84(3):349-350. PubMed ID: 37188550
[No Abstract] [Full Text] [Related]
12. Reply to Tianrui Feng, Miao Ren, and Zhien Zhou's Letter to the Editor re: Peter Fletcher, Marta De Santis, Simona Ippoliti, et al. Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia. Eur Urol 2023;83:249-56.
Fletcher P; Kastner C
Eur Urol; 2023 Nov; 84(5):e115. PubMed ID: 37202313
[No Abstract] [Full Text] [Related]
13. Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
Baco E; Rud E; Vlatkovic L
Eur Urol; 2016 Aug; 70(2):e55. PubMed ID: 26852076
[No Abstract] [Full Text] [Related]
14. Reply to Zhipeng Mai's Letter to the Editor re: Taimur T. Shah, Max Peters, David Eldred-Evans, et al. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry. Eur Urol 2019;76:98-105.
Shah TT; Peters M; Arya M; Ahmed HU
Eur Urol; 2019 Sep; 76(3):e63-e64. PubMed ID: 31153649
[No Abstract] [Full Text] [Related]
15. Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
Chesnut GT; Vertosick EA; Ehdaie B
Eur Urol; 2020 Aug; 78(2):e65-e66. PubMed ID: 32386781
[No Abstract] [Full Text] [Related]
16. Reply to Kunlin Yang, Xuesong Li, and Liqun Zhou's Letter to the Editor re: Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al. Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration. Eur Urol 2021;79:133-40.
Roussel E; Tasso G; Albersen M
Eur Urol; 2021 Jul; 80(1):e32. PubMed ID: 33941401
[No Abstract] [Full Text] [Related]
17. Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.
Goonewardene SS; Persad R; Young A; Makar A
Eur Urol; 2014 Sep; 66(3):e51-2. PubMed ID: 24813269
[No Abstract] [Full Text] [Related]
18. Reply to Michael Froehner's letter to the editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8.
Nepple KG; Kibel AS
Eur Urol; 2014 Mar; 65(3):e42. PubMed ID: 24315707
[No Abstract] [Full Text] [Related]
19. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.
Trock BJ; Karnes RJ
Eur Urol; 2017 Dec; 72(6):e158-e159. PubMed ID: 28576503
[No Abstract] [Full Text] [Related]
20. Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Van den Broeck T; Wiegel T;
Eur Urol; 2020 Sep; 78(3):e120-e121. PubMed ID: 32684306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
